SCHEMBL87256

SCHEMBL87256

C=C(C)CSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL386613 0.74 HSD17B10 (0.41)
SCHEMBL459298 0.74
SCHEMBL10015725 0.74
SCHEMBL1018195 0.71
SCHEMBL17232428 0.71
SCHEMBL294410 0.69
SCHEMBL20464013 0.69
SCHEMBL87260 0.69
SCHEMBL14414574 0.69
SCHEMBL87085 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192908-B2 Octamolybdate compounds exhibiting bright emission NANOCO 2D MATERIALS LIMITED (GB) 2021-12-07 US disclosed
EP-3837267-A1 POLYOXOMETALATE COMPOUNDS EXHIBITING BRIGHT EMISSION AND METHODS OF PRODUCING THE SAME Nanoco 2D Materials Limited (GB) 2021-06-23 EP disclosed
CN-112533934-A Polyoxometallate compounds exhibiting bright emission and methods of making the same 纳米2D材料有限公司 2021-03-19 CN disclosed
US-10701931-B2 Mosquito activating formulations COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2020-07-07 US disclosed
WO-2020035670-A1 POLYOXOMETALATE COMPOUNDS EXHIBITING BRIGHT EMISSION AND METHODS OF PRODUCING THE SAME NANOCO 2D MATERIALS LIMITED (GB) 2020-02-20 WO disclosed
US-20200055884-A1 Octamolybdate Compounds Exhibiting Bright Emission NANOCO TECHNOLOGIES LIMITED (GB) 2020-02-20 US disclosed
US-20190208777-A1 MOSQUITO ACTIVATING FORMULATIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2019-07-11 US disclosed
CN-108471744-A Mosquito-activating agent 联邦科学技术研究组织 2018-08-31 CN disclosed
EP-3361867-A1 MOSQUITO ACTIVATING FORMULATIONS Commonwealth Scientific and Industrial Research Organisation (AU) 2018-08-22 EP disclosed
WO-2017106914-A1 METHOD OF SCREENING COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-06-29 WO disclosed
US-7270883-B2 Film-forming composition, anti-reflection film, polarizing plate, image display apparatus, anti-pollution coating composition and anti-pollution article FUJIFILM CORPORATION (JP) 2007-09-18 US disclosed
US-7264329-B2 Inkjet recording head and inkjet recording device FUJIFILM CORPORATION (JP) 2007-09-04 US disclosed
WO-2007063702-A2 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 WO disclosed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP disclosed
US-5594132-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-01-14 US disclosed
US-5026695-A Gram negative-gram positive microbiocides, oral adminis tration FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-06-25 US disclosed
US-4904652-A 7-acylamino-3-substituted cephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-27 US disclosed
EP-0029557-B1 7-ACYLAMINO-3-SUBSTITUTED CEPHALOSPORANIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-03-13 EP disclosed
US-4462999-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-31 US disclosed
US-4409215-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-11 US disclosed